Tharun is a Chartered Financial Analyst from the CFA Institute, U.S. A graduate from Loyola College, Chennai, he started his career in Goldman Sachs at their Bangalore office. Prior to his current role at Proactive Investors, he worked as an equity analyst at a global research and analytics company in Mumbai, assisting institutional clients across Asia.
The company's shares are trading about 47% higher intra-day, at 2.5 cents.
Additional funding to complete the pre-feasibility study and feasibility study for Finniss.
Toro’s flagship asset is the 100% owned Wiluna Uranium Project, consisting of six calcrete-hosted uranium deposits.
Admedus is aiming to revolutionise the design and engineering of transcatheter aortic valve replacement (TAVR) devices.
Regeneus’ Progenza is a stem cell technology platform developed for the treatment of knee osteoarthritis.
Cann is scaling up substantially to compete on the global medicinal cannabis stage.
OncoSil is a first in class medical device for the treatment of unresectable locally advanced pancreatic cancer.
Technology to communicate and commercially transact with people using transit environments via their mobile devices.